Kyndryl Holdings (NYSE:KD) recently announced an expanded partnership with Google Cloud, focusing on using generative AI to modernize mainframe applications. Despite these positive announcements, ...

Kyndryl partners with Dr Reddy’s Laboratories to transform IT operations with AI-powered digital platform for automation and ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the it services & consulting stocks, including Kyndryl ...

NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Kyndryl ...

IT services giant Kyndryl has partnered with Dr Reddy’s Laboratories to revamp the pharmaceutical company’s IT operations ...

Kyndryl Holdings ( KD -8.00%) is the target of a report from a short-seller that accuses the IT infrastructure company of ...

NEW YORK, NY / ACCESS Newswire / April 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Kyndryl ...

In the most recent trading session, Kyndryl Holdings, Inc. (KD) closed at $28.23, indicating a -1.74% shift from the previous trading day.

Health care tech leaders need to play a larger role in their organizations' financial strategies this year, Kyndryl's Trent ...

Kyndryl has expanded its relationship with Google Cloud to tap into generative AI (gen AI) to accelerate the modernisation of ...

Shares of Kyndryl fell nearly 13% on Thursday, after a research report from short-seller Gotham City alleged the IT services provider has manipulated certain financial metrics.

Kyndryl, a leading provider of mission-critical enterprise technology services, on Monday announced that it has partnered with Hyderabad-based Pharma giant Dr. Reddy’s Laboratories, a leading Indian ...